ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHELE MCMAHON MD

Internal Medicine

582

$31.5K

141
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

ANITHA NAGAPPAN M.D.

Internal Medicine

937

$31.2K

217
182 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$33
Average prescription price

Avg: $56

ROBERTO GARCIA MD

Internal Medicine

696

$31.2K

180
102 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

PURAV PARMAR M.D

Internal Medicine

399

$31.1K

144
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$78
Average prescription price

Avg: $56

SUNITHA KALUVEHALLIMATTA MBBS

Internal Medicine

754

$30.3K

69
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

YOHANNES BELACHEW M.D

Internal Medicine

1,044

$30.2K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$29
Average prescription price

Avg: $56

FERDINAND OSUJI MD

Internal Medicine

676

$30K

234
149 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

ALEXANDR BABAYEUSKI MD

Internal Medicine

686

$30K

131
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

RALPH AUSTIN M.D.

Internal Medicine

979

$29.7K

238
145 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $56

DAVID ROWAN

Internal Medicine

607

$29.6K

64
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

DAWIT ANTONIOS MD

Internal Medicine

680

$29.1K

242
146 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $56

ALICE WEI YOU MD

Internal Medicine

971

$28.8K

89
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $56

SYLVANUS FIAKPORNOO MD

Internal Medicine

688

$28.7K

187
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

MARILYN DIGAMON-BELTRAN MD

Internal Medicine

837

$28.7K

62
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

KRISHNAN ARUNACHALAM M.D.

Internal Medicine

1,108

$28.7K

45
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 26%

$26
Average prescription price

Avg: $56

BRENDAN GROARKE D.O.

Internal Medicine

650

$28.4K

200
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

LAWTON DAVIS M.D.

Internal Medicine

188

$28.1K

172
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

89%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $56

RAMI REDDY BONAM M.D.

Internal Medicine

820

$27.6K

89
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

CHRISTOPHER PHILLIPS MD

Internal Medicine

457

$27.5K

70
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

RYAN CARRICK M.D.

Internal Medicine

329

$27.3K

144
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $56

TODD MEADOWS M.D.

Internal Medicine

565

$27K

56
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

ELIZABETH SOLOMON MD

Internal Medicine

675

$26.8K

80
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

SUSMITA PARASHAR MD

Internal Medicine

436

$26.1K

67
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

JOHN SHANER M.D.

Internal Medicine

694

$26.1K

104
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

IGOR LEGOSTAEV M.D.

Internal Medicine

602

$25.7K

144
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank